NO985518D0 - Morfinanderivater og medisinsk anvendelse derav - Google Patents
Morfinanderivater og medisinsk anvendelse deravInfo
- Publication number
- NO985518D0 NO985518D0 NO985518A NO985518A NO985518D0 NO 985518 D0 NO985518 D0 NO 985518D0 NO 985518 A NO985518 A NO 985518A NO 985518 A NO985518 A NO 985518A NO 985518 D0 NO985518 D0 NO 985518D0
- Authority
- NO
- Norway
- Prior art keywords
- medical use
- morphine derivatives
- morphinan derivatives
- opioid
- epsilon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7634097 | 1997-03-27 | ||
PCT/JP1998/001376 WO1998043978A1 (fr) | 1997-03-27 | 1998-03-27 | Derives de morphinane et usage medical de ces derniers |
Publications (2)
Publication Number | Publication Date |
---|---|
NO985518D0 true NO985518D0 (no) | 1998-11-26 |
NO985518L NO985518L (no) | 1999-01-21 |
Family
ID=13602637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO985518A NO985518L (no) | 1997-03-27 | 1998-11-26 | Morfinanderivater og medisinsk anvendelse derav |
Country Status (12)
Country | Link |
---|---|
US (1) | US6187782B1 (no) |
EP (1) | EP0915094B1 (no) |
KR (1) | KR20000016052A (no) |
CN (1) | CN1150196C (no) |
AT (1) | ATE377602T1 (no) |
AU (1) | AU743929B2 (no) |
CA (1) | CA2256897C (no) |
DE (1) | DE69838662T2 (no) |
ES (1) | ES2297882T3 (no) |
NO (1) | NO985518L (no) |
NZ (1) | NZ333101A (no) |
WO (1) | WO1998043978A1 (no) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2383146C (en) * | 1999-08-24 | 2010-11-16 | Hiroshi Nagase | Therapeutic agent for neuropathic pain and neuropathic pain animal model |
US20080125592A1 (en) * | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
CA2674915C (en) * | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
AU2012216358B2 (en) * | 2006-10-17 | 2014-11-20 | Penick Corporation | Process For Preparing Oxymorphone, Naltrexone and Buprenorphine |
EP2073636B1 (en) * | 2006-10-17 | 2012-09-05 | Penick Corporation | Process for preparing oxymorphone |
DK3825306T3 (da) | 2007-05-01 | 2023-09-11 | Sun Pharmaceutical Ind Inc | Morphinanforbindelser |
MX370608B (es) | 2007-05-01 | 2019-12-18 | Concert Pharmaceuticals Inc | Compuestos de morfinano. |
JP5252391B2 (ja) * | 2008-02-21 | 2013-07-31 | 学校法人北里研究所 | オキサビシクロ[2.2.2]オクタンを有するモルヒナン誘導体およびその医薬用途 |
US8686158B2 (en) | 2008-06-05 | 2014-04-01 | President And Fellows Of Harvard College | High-valent palladium fluoride complexes and uses thereof |
EP2356989B1 (en) * | 2008-10-24 | 2018-02-07 | Toray Industries, Inc. | Stable tablet containing 4,5-epoxymorphinan derivative |
WO2010059943A2 (en) | 2008-11-20 | 2010-05-27 | President And Fellows Of Harvard College | Fluorination of organic compounds |
CN102341389A (zh) * | 2009-01-09 | 2012-02-01 | 哈佛学院董事会 | 含氟化合物和其使用方法 |
JP2014073964A (ja) * | 2011-01-28 | 2014-04-24 | Kitasato Institute | モルヒナン誘導体 |
CN103596931B (zh) | 2011-04-12 | 2016-10-12 | 哈佛大学校长及研究员协会 | 有机化合物的氟化 |
DK2774926T3 (en) | 2011-09-09 | 2017-05-15 | The Kitasato Inst | morphinan |
WO2014021273A1 (ja) * | 2012-07-30 | 2014-02-06 | 学校法人北里研究所 | モルヒナン誘導体 |
WO2014052622A1 (en) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Nickel fluorinating complexes and uses thereof |
EP2941433B1 (en) | 2012-12-31 | 2019-08-07 | Rhodes Technologies | Process for preparing 7 -substituted 6 ,14 -ethenomorphinans and 7 -substituted 6 ,14 -ethanomorphinans |
US8969358B2 (en) | 2013-03-15 | 2015-03-03 | Purdue Pharma L.P. | Buprenorphine analogs |
US10759764B2 (en) | 2013-10-18 | 2020-09-01 | President And Fellows Of Harvard College | Fluorination of organic compounds |
JP6814470B2 (ja) * | 2017-02-10 | 2021-01-20 | 国立大学法人 筑波大学 | モルヒナン誘導体 |
WO2019045006A1 (ja) * | 2017-08-31 | 2019-03-07 | 日本ケミファ株式会社 | モルヒナン誘導体 |
WO2019168025A1 (ja) * | 2018-02-28 | 2019-09-06 | 日本ケミファ株式会社 | モルヒナン誘導体の製造方法 |
JP2021104932A (ja) * | 2018-03-30 | 2021-07-26 | 日本ケミファ株式会社 | モルヒナン誘導体の製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2229770A1 (de) | 1972-06-19 | 1974-01-10 | Boehringer Sohn Ingelheim | N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung |
JPS6163658A (ja) | 1984-07-05 | 1986-04-01 | ザ・デュポン・メルク・ファーマシュウティカル・カンパニー | 3−ヒドロキシモルフイナン類の置換ベンゾエ−トエステルプロドラツグ誘導体 |
PT95069B (pt) | 1989-08-24 | 1997-10-31 | Searle & Co | Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos |
AU666702B2 (en) | 1992-01-23 | 1996-02-22 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
-
1998
- 1998-03-27 CA CA002256897A patent/CA2256897C/en not_active Expired - Fee Related
- 1998-03-27 KR KR1019980709619A patent/KR20000016052A/ko not_active Application Discontinuation
- 1998-03-27 EP EP98911044A patent/EP0915094B1/en not_active Expired - Lifetime
- 1998-03-27 NZ NZ333101A patent/NZ333101A/xx unknown
- 1998-03-27 ES ES98911044T patent/ES2297882T3/es not_active Expired - Lifetime
- 1998-03-27 US US09/194,366 patent/US6187782B1/en not_active Expired - Fee Related
- 1998-03-27 AU AU65189/98A patent/AU743929B2/en not_active Ceased
- 1998-03-27 CN CNB988003864A patent/CN1150196C/zh not_active Expired - Fee Related
- 1998-03-27 DE DE69838662T patent/DE69838662T2/de not_active Expired - Fee Related
- 1998-03-27 WO PCT/JP1998/001376 patent/WO1998043978A1/ja active IP Right Grant
- 1998-03-27 AT AT98911044T patent/ATE377602T1/de not_active IP Right Cessation
- 1998-11-26 NO NO985518A patent/NO985518L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0915094A4 (en) | 2004-09-22 |
NZ333101A (en) | 2000-05-26 |
CN1220667A (zh) | 1999-06-23 |
DE69838662T2 (de) | 2008-08-28 |
AU743929B2 (en) | 2002-02-07 |
AU6518998A (en) | 1998-10-22 |
EP0915094B1 (en) | 2007-11-07 |
NO985518L (no) | 1999-01-21 |
CN1150196C (zh) | 2004-05-19 |
US6187782B1 (en) | 2001-02-13 |
CA2256897A1 (en) | 1998-10-08 |
EP0915094A1 (en) | 1999-05-12 |
KR20000016052A (ko) | 2000-03-25 |
DE69838662D1 (de) | 2007-12-20 |
ATE377602T1 (de) | 2007-11-15 |
ES2297882T3 (es) | 2008-05-01 |
CA2256897C (en) | 2006-10-03 |
WO1998043978A1 (fr) | 1998-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO985518L (no) | Morfinanderivater og medisinsk anvendelse derav | |
ATE212978T1 (de) | Para-substituierte phenylpropansäure derivate als integrin-antagonisten | |
ATE324371T1 (de) | N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten | |
JO2371B1 (en) | 4-phenyl-pyridine derivatives | |
BG66094B1 (bg) | Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства | |
BR0312934A (pt) | Derivados de 8-hidróxi quinolina | |
EA200500814A1 (ru) | Производные пирролопиримидина | |
ATE377589T1 (de) | 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten | |
ATE350036T1 (de) | Tetrahydroquinolin-derivate | |
ATE414516T1 (de) | Morphinanderivate als mittel gegen juckreiz | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
MXPA04000278A (es) | Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales. | |
MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
DK1543010T3 (da) | N-substituerede hydromorphoner og anvendelse deraf | |
EA200400467A1 (ru) | Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора | |
ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
ATE352543T1 (de) | Ein dioxino(2,3-g)chinolin-9-carbonsäure derivat als nk3 rezeptor antagonist | |
DE60302157D1 (de) | Opioidrezeptorantagonisten | |
ATE210118T1 (de) | N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten | |
ATE318266T1 (de) | 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten | |
DE69935670D1 (de) | Behandlung von dyskinesie durch mu-selektive opioidantagonisten | |
EA200301120A1 (ru) | Цитрат 5,8,14-триазатетрацикло (10.3.1.0.0)-гексадека-2 (11),3,5,7,9-пентаена | |
EA200301203A1 (ru) | Новые соединения и композиции как ингибиторы катепсина | |
WO2001010860A3 (en) | Quinazolinone and azaquinazolinone derivatives |